Rifamycin SV MMX for the treatment of traveler’s diarrhea

@article{Lin2017RifamycinSM,
  title={Rifamycin SV MMX for the treatment of traveler’s diarrhea},
  author={Shu-wen Lin and Chun-Jung Lin and Jyh-Chin Yang},
  journal={Expert Opinion on Pharmacotherapy},
  year={2017},
  volume={18},
  pages={1269 - 1277}
}
  • Shu-wen Lin, Chun-Jung Lin, Jyh-Chin Yang
  • Published 2017
  • Medicine
  • Expert Opinion on Pharmacotherapy
  • ABSTRACT Introduction: Rifamycin SV MMX®, a non-absorbable rifamycin antibiotic formulated using the multi-matrix system, was designed to exhibit its pharmacological action on the distal small intestine and colon. Its clinical efficacy and safety profile in the treatment of traveler’s diarrhea were evaluated in several clinical studies. Areas covered: This review summarizes all available evidence regarding clinical trials of the efficacy and safety profile of rifamycin SV MMX for the treatment… CONTINUE READING
    1 Citations

    References

    SHOWING 1-10 OF 85 REFERENCES
    Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.
    • 18
    • Highly Influential
    • PDF
    Rifaximin: A Nonabsorbed Antimicrobial in the Therapy of Travelers’ Diarrhea
    • 90
    Targeted therapy in travelers' diarrhea: what is the role for the non-absorbable?
    • 4
    • PDF
    Rifaximin in the Treatment of Infectious Diarrhea
    • 18
    Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders.
    • J. Adachi, H. DuPont
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2006
    • 113
    • PDF
    Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.
    • 176
    • PDF
    Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
    • 80
    Therapy of travelers’ diarrhea with rifaximin on various continents
    • 130
    • Highly Influential
    Nonantimicrobial agents in the prevention and treatment of traveler's diarrhea.
    • C. Ericsson
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2005
    • 36
    • PDF
    In Vitro Activity and Single-Step Mutational Analysis of Rifamycin SV Tested against Enteropathogens Associated with Traveler's Diarrhea and Clostridium difficile
    • 10
    • Highly Influential
    • PDF